Monkeypox?! Pharma Power Stock Fights This Infectious Virus
At the time of writing, 41 states have reported at least one case of monkeypox — a virus that this 93-rated Power Stock’s drug treats.
Posted by Matthew Clark | Jul 15, 2022 | Money & Markets Daily
At the time of writing, 41 states have reported at least one case of monkeypox — a virus that this 93-rated Power Stock’s drug treats.
Posted by Matthew Clark | Jul 14, 2022 | Money & Markets Daily
The value of commercial insurance rose 35% from 2013 to 2020, and it’s going higher from here. This Power Stock underwrote $2.9 billion worth of insurance just last quarter and rates a 93 on our system.
Posted by Matthew Clark | Jul 13, 2022 | Money & Markets Daily
The wire transfer market value will jump 185% by 2025. This Power Stock helps folks send money transfers and rates a 97 on our system.
Posted by Matthew Clark | Jul 12, 2022 | Investing
It’s more important than ever for stores to keep their shelves well-stocked. Here’s why this logistics stock is set to lead the pack.
Posted by Matthew Clark | Jul 12, 2022 | Money & Markets Daily
The diagnostic testing market in the U.S. will eclipse $30 billion by 2023. This Power Stock makes rapid tests and scores a 98 on our system.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below